Israel’s Newsight (reported here previously) has developed a spectral signature virus test that it says identifies Covid-19 in a blood or saliva sample in less than a second. A pilot trial of the test is to be performed at Israel’s Sheba Medical Center where Newsight has been working in the tropical diseases dept.